Immunity to halothane metabolite-modified proteins in halothane hepatitis (Q42288415)

19 October 2017

title

Immunity to halothane metabolite-modified proteins in halothane hepatitis (English)

1 reference

19 October 2017

1 reference

J G Kenna

1 reference

19 October 2017

T L Knight

series ordinal

1 reference

19 October 2017

F N van Pelt

series ordinal

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 June 1993

1 reference

Annals of the New York Academy of Sciences

19 October 2017

1 reference

inferred from page(s)

published in

1 reference

19 October 2017

volume

685

1 reference

19 October 2017

page(s)

646-661

1 reference

Controlled prospective study of the effect on liver function of multiple exposures to halothane

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35930.X

Controlled trial of repeated halothane anaesthetics in patients with carcinoma of the uterine cervix treated with radium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35930.X

Halothane hepatitis: a model of immune mediated drug hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35930.X

An enzyme-linked immunosorbent assay for detection of antibodies against halothane-altered hepatocyte antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35930.X

The molecular basis of halothane-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35930.X

Enzyme Topology of Intracellular Membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35930.X

The topography of trifluoroacetylated protein antigens in liver microsomal fractions from halothane treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35930.X

Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35930.X

The calcium-binding protein calreticulin is covalently modified in rat liver by a reactive metabolite of the inhalation anesthetic halothane

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35930.X

A metabolite of halothane covalently binds to an endoplasmic reticulum protein that is highly homologous to phosphatidylinositol-specific phospholipase C-alpha but has no activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35930.X

The retention signal for soluble proteins of the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35930.X

Halothane metabolism: Kupffer cells carry and partially process trifluoroacetylated protein adducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35930.X

Molecular mimicry of trifluoroacetylated human liver protein adducts by constitutive proteins and immunochemical evidence for its impairment in halothane hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35930.X

10.1111/J.1749-6632.1993.TB35930.X

21 January 2018

Identifiers

DOI

1 reference

19 October 2017

1 reference